Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03603496 · ClinicalTrials.gov registry record · Phase 4
Post-Discharge Smoking Cessation Strategies: Helping HAND 4
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,416
- Enrollment target
NCT03603496: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT03603496 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,416 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (173% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03603496, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,416 participants
- Enrollment target
Study Summary
This randomized controlled trial will compare the effectiveness of two models of post-discharge tobacco cessation treatment for adult smokers admitted to 3 U.S. hospitals.
Primary Outcome
Participant self-report of no use of any tobacco product (cigarettes, cigars, little cigars, pipes, smokeless tobacco product) in the past 7 days AND either a saliva sample with a cotinine concentration \<=10 ng/ml OR breath sample with a carbon monoxide concentration \<=9 ppm.
Interventions
- DRUG Nicotine replacement therapy
- BEHAVIORAL Transitional Tobacco Care Management (TTCM)
- BEHAVIORAL eReferral to State Tobacco Quitline (QL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,416 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2020-11-17 |
| Phase | Phase 4 |
What the finished NCT03603496 record still lists
NCT03603496 is an interventional study that assigns participants to a tested intervention. Its 1,416 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (173% higher).
The record links to 0 conditions, and to 3 interventions - of which Nicotine replacement therapy is the first listed.
NCT03603496 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03603496 about?
NCT03603496 is a clinical study titled "Post-Discharge Smoking Cessation Strategies: Helping HAND 4". This randomized controlled trial will compare the effectiveness of two models of post-discharge tobacco cessation treatment for adult smokers admitted to 3 U.S. hospitals.
What is the current status of trial NCT03603496?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,416 participants. The study started on 2018-09-01. Estimated completion is 2020-11-17.
What interventions are being tested in trial NCT03603496?
The interventions under investigation include: Nicotine replacement therapy (DRUG), Transitional Tobacco Care Management (TTCM) (BEHAVIORAL), eReferral to State Tobacco Quitline (QL) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03603496?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03603496's enrollment target sits among peer trials
1,416 54th of 2000 higher than 1,947 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05890404 · 1,410 participants · NA
SGM Evidenced-Based Mental Healthcare Implementation
- NCT07042451 · 1,410 participants · NA
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
- NCT07222566 · 1,410 participants · Phase 3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT05992935 · 1,405 participants · Phase 1
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI